For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with ...

According to Ultimate Classic Rock, Joe Zocco filled in for the guitarist during the band's performance in Leon, Mexico on ...

Def Leppard played their first concert of 2025 without guitarist Vivian Campbell, who was absent due to cancer treatment, in ...

Vivian Campbell has missed both shows Def Leppard have played since the finish of last year's Summer Stadium Tour ...

Campbell, the guitarist for Def Leppard, made headlines this week because he missed the band’s first show of 2025 which took ...

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Def Leppard guitarist Vivian Campbell missed the band's first concert of 2025 due to his recovery from cancer treatment.

Merck (MRK) stock in focus as the company eyes 2025 launch of subcutaneous Keytruda amid a looming patent cliff for its ...

Merck accelerates subcutaneous Keytruda rollout to protect cancer drug's dominance as IV patent nears 2028 expiry.

BBO-8520, an investigational oral agent, has been granted fast track designation from the FDA in previously treated KRAS G12C ...

Werewolf Therapeutics (HOWL) provided a business update and outlined its strategic outlook and expected milestones for 2025. ...